Screener
Trevi Therapeutics, Inc. TRVI Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206390
| Assets | March 31,2026 / Unaudited | December 31,2025 |
|---|---|---|
| Accrued expenses | 4,582 | 5,531 |
| Operating lease liabilities | 318 | 307 |
| Total current liabilities | 7,115 | 9,749 |
| Operating lease liabilities | 364 | 446 |
| Total liabilities | 7,479 | 10,195 |
| Commitments and contingencies (Note 10) | ||
| Stockholders’ equity: | ||
| Preferred stock: $0.001 par value; 5,000,000 shares authorized at March 31, 2026 and December 31, 2025; no shares issued or outstanding at March 31, 2026 and December 31, 2025. | — | — |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is Trevi Therapeutics, Inc.'s operating lease liabilities?
- Trevi Therapeutics, Inc. (TRVI) reported operating lease liabilities of $364K in Q1 2026.
- How has Trevi Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
- Trevi Therapeutics, Inc.'s operating lease liabilities decreased by 46.5% year-over-year, from $681K to $364K.
- What is the long-term trend for Trevi Therapeutics, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s operating lease liabilities has grown at a 25.4% compound annual growth rate (CAGR), from $144K to $446K.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Trevi Therapeutics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude